Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Long before giant pharmaceutical companies started stamping their logos on excipient containers, glyceryl monostearate (GMS) and glyceryl distearate quietly showed up in both household and therapeutic products. Chemists investigated the value of fatty acid monoglycerides and diglycerides around the turn of the 20th century, drawn in by their capacity to blend oil and water. By the 1950s, the pharmaceutical world recognized these compounds as reliable emulsifiers, lending a hand in creams and ointments and anchoring countless oral dosage forms. Since then, regulatory benchmarks like BP, EP, and USP standards started tightening, but by then, GMS and Distearate had already earned trust as consistent, well-understood ingredients. For someone working with pharmaceutical formulations, the familiarity of these substances stands out, a reminder that progress in science usually means refining the old tools rather than tossing them.
Glyceryl monostearate and glyceryl distearate show up as white to off-white waxy flakes or powder. Suppliers list them under pharma grade when they meet the strict quality checks by BP, EP, or USP—each abbreviation a shorthand for pharmacopoeias ensuring product integrity. Both serve as emulsifiers, stabilizers, and release agents, helping active ingredients stay together or break apart as needed. Their real value sinks in during hands-on blending or tablet pressing. Some days, GMS helps granules bind, while GDS leans into lubrication for a smooth press-out. Depending on the fatty acid chain makeup and purity, their waxy texture takes on various melting points and soluble characteristics, useful when juggling multiple formulations.
Both glyceryl monostearate and glyceryl distearate belong to the ester family. Their molecular backbone unites glycerol with stearic acid mono- or diesters, giving them a waxy solid look. Their melting points hover around 58°C–70°C, sometimes a bit higher for distearate. At room temperature, they hold their structure, yet in the lab, their low solubility in water and excellent dispersibility in oils make them champions for creams and ointments. Chemical tests show high stability, especially when stored in a cool, dry place away from sunlight. Their pH stays steady, and their tendencies for hydrolysis or oxidation run low, which means less chance of formulation breakdown over time.
Regulatory bodies put pharma grade glyceryl monostearate and distearate under tight scrutiny. Each batch report must show precise acid value, saponification value, and purity—generally above 90% for GMS and similar tight specs for GDS. Heavy metal limits, microbial counts, and residue on ignition data all stay within the narrow bands set by BP, EP, and USP. Labels demand clarity, calling out batch number, manufacture date, and any additives present. In my experience, skimping here means risking a failed audit or worse—formulation problems downstream. It pays to double-check the label before pouring into a batch tank.
Industrial producers rely on the esterification of glycerol with stearic acid, running the reaction at elevated temperatures often under vacuum. Catalysts like acidic resins speed the reaction. Once complete, the mix cools then gets purified through distillation or crystallization, depending on whether monostearate or distearate is the goal. In smaller labs, the focus shifts from high through-put to precision temperature and pH control. A poorly-tuned esterification results in unreacted glycerol, lower purity, and possible issues with tablet hardness or release profiles. Years working in compounding taught me that temperature swings during synthesis throw off the end product much more than most people expect.
Both GMS and GDS show remarkable stability, but chemical tweaks can boost function. Through partial hydrogenation, producers adjust melting points or tweak texture to suit topical applications. Transesterification increases monoester content, especially valued for emulsifiers. Blending with other fatty acid esters or incorporating surfactants widens their utility for specialized formulations, say sustained-release tablets or water-resistant topical ointments. Chemical modifications must keep an eye on potential residual catalysts or by-products. The ripple effect of a single contaminant—an issue I’ve run into running scale-ups—can set off a cascade of problems, from altered dissolution curves to poor patient compliance.
Suppliers and pharmacopoeias use several names for these compounds. Glyceryl monostearate often appears as GMS, 1-monostearin, or E471. Glyceryl distearate may show up as GDS, diglyceryl stearate, or E472(a). Across different regions and supply chains, these synonyms matter, especially checking certificates of analysis or customs records. Years of ordering excipients have shown me that mismatched synonyms between documents can stall a shipment or derail a batch if not caught early.
Pharmaceutical companies lean heavily on safety protocols when handling glyceryl monostearate and distearate. They demand low dust, non-toxic excipients to manage worker exposure and patient safety. Factories run routine dust control, mandate gloves and masks, and track batch traceability from vendor to finished tablet. Regulatory authorities demand validation of every cleaning and calibration step, as carryover or cross-contamination brings lawsuits and recalls. Training session after training session drove home how no shortcut on safety pays off, even for ingredients that rarely set off hazard alarms.
These two excipients do a lot of quiet heavy lifting. In tablets and capsules, they work as lubricants for smooth ejection and uniform dosing. Creams, lotions, and ointments rely on their strong emulsifying properties to keep actives dispersed and stable. In suppository preparations, their waxy texture enhances melting and release performance. Food and cosmetic industries also lean on GMS for its stabilizer and thickener roles. Every time a pharmaceutical lab scales a poorly lubricated batch, the risk of sticking or capping jumps—something a pinch of the right GMS or GDS can fix instantly.
Modern R&D teams don’t just test for basic function anymore. Investigators push glyceryl monostearate and distearate through biocompatibility, advanced dissolution, and controlled-release trials. They combine these excipients with novel drug carriers or polymer matrices to extend drug action or boost bioavailability. Some research pivots on tweaking crystalline forms to alter melting behavior, a trick for both oral and topical delivery systems. Trial and error—sometimes dozens of failed test batches—drives most of the technical tweaks that end up changing product labels or patent filings. Years spent behind the bench mean appreciating not just what GMS or GDS does, but what they make possible in combination with other functional excipients.
Toxicology data backs up GMS and GDS’s track record as safe excipients; oral LD50 values hover well above safety margins and repeated dose studies flag no significant systemic risk. Chronic exposure studies in both animals and cell cultures point to little risk of bioaccumulation or irritation. For immunocompromised or sensitive patient populations, careful attention to potential impurities or unreacted starting materials still matters. Too many formulators overlook that even “safe” excipients need regular retesting as analytical methods improve and new regulatory guidance rolls out.
As pharma chases new delivery technologies, glyceryl monostearate and distearate probably won’t headline academic journals, but demand for them keeps rising, especially as more oral solids, topicals, and biologics hit the market. The push toward clean-label excipients, sustainable sourcing, and improved patient compliance highlights these long-standing ingredients for their predictability and long record of use. Green chemistry projects also point to glyceryl esters as building blocks for low-impact production. In my own work, seeing these excipients survive countless reformulations and regulatory shifts assured me some lab staples never fade away—they just quietly support every new wave of innovation.
Years spent working with medication delivery have revealed just how much people rely on substances most have never heard of. Glyceryl Monostearate and Glyceryl Distearate keep making their way onto ingredient lists because they solve some practical problems faced by both pharmacists and drug manufacturers. These aren’t fancy miracle cures, but without them, your standard pill or cream really struggles to do its job.
Every person who has ever swallowed a tablet expects it to go down easy and start working quickly. That smooth shell and even texture don’t just happen by chance. Glyceryl Monostearate steps in as a practical lubricant. It makes powders less sticky and eases the compression process. Tablets that leave the factory with GMS or Distearate in the mix suffer from fewer hard edges. There’s less risk they chip or crumble during packaging, transport, or when customers open the bottle.
Anyone who’s ever bitten into a bitter-tasting tablet understands the value of a protective coat. GMS can help with this, forming a kind of barrier that masks taste and blocks moisture. That extra layer makes drugs less likely to break down before their time. These improvements show up in patient satisfaction and shelf life stats—fewer returns, fewer complaints, more confidence at the pharmacy counter.
Mixing oil and water ranks as a classic pharmacy problem. Glyceryl Monostearate steps up as an emulsifier. Applying a moisturizer or a medicated cream and finding it smooth, not oily, owes a debt to this ingredient. It helps blend fats and water so products go on evenly. Spreading a medicinal cream and watching it disappear into the skin feels pleasant. Patients don’t want greasy residue or strong smells, and these glyceryl compounds help companies deliver just that: something gentle, easy to spread, and stable over time.
Stability in topical drugs isn’t just about comfort. A stable cream delivers the same dose from the start of the tube to the very end. Fewer clumps or oily patches mean doctors and patients know what to expect every time they use the product. Pharmacies avoid messy refunds and clients trust what they’re getting.
The labels BP, EP, and USP matter for safety. Each refers to a different set of rules—the British Pharmacopoeia, European Pharmacopoeia, and United States Pharmacopeia. Glyceryl Monostearate and Distearate produced to these standards help build trust in medicines worldwide. Companies stick with suppliers who can show a certificate from these regulatory bodies, and for good reason. Without verified quality, questions start popping up about consistency, purity, and contamination. Hospitals, clinics, and patients can’t afford those kinds of risks.
Reliable suppliers for pharmaceutical-grade excipients add another level of protection for end users. Drug recalls often track back to issues with so-called “inert” ingredients. Strict quality control prevents headaches all the way through the supply chain.
For researchers, exploring new combinations or delivery systems begins with trusted basics like GMS and Distearate. There’s room to improve how drugs dissolve in the body, how long effects last, or even how medicines feel when applied to the skin. Flexible and reputable ingredients support safe innovation.
Every time a patient finds relief from a reliable tablet or cream, there’s years of ingredient testing, regulatory focus, and simple problem solving behind it. Glyceryl Monostearate and Distearate anchor that effort, streamlining manufacturing and protecting medicine quality. Out on the front lines, every improvement in stability or handling helps both patients and healthcare professionals alike.
Years of reading labels on lotions taught me how often glyceryl monostearate and glyceryl distearate pop up in personal care and food products. They sound similar, and both come from the reaction of glycerin with stearic acid, a fatty acid found in plants and animals. Their differences show up in small but significant ways — ways that shape how our skin feels or how a product looks and performs.
Glyceryl monostearate, often shortened to GMS, contains one stearic acid molecule attached to the glycerin backbone. Manufacturers like using GMS in creams and lotions for its creamy texture and ability to help oil and water stay mixed. This ingredient mimics the moisturizing action of natural skin lipids, which helps keep skin smooth and hydrated. It thickens lotions just enough, makes them spread easily, and adds a subtle silky finish. I’ve seen GMS used in whipped body butters and sunscreen to keep them from separating and turning gritty on the shelf or in the sun.
Glyceryl distearate contains two stearic acid groups. Compared to GMS, it gives products a richer, smoother texture and imparts a pearlescent look to shampoos and body washes. If you’ve puzzled over what creates that soft shimmer in your favorite shower gel, it’s often this ingredient at work. GDS helps make products feel plush and glide more easily over skin or hair. This ingredient can also help lock moisture in, but it creates a heavier layer, so it shows up more often in products where shine and smoothness matter most, like creamy cleansers and conditioning hair products.
On paper, the swap of one fatty acid for two looks minor. In practice, this creates options for formulators and impacts performance in ways that people notice: GMS keeps things light and fluffy, so it goes in products looking for a fresh skin feel and gentle moisturization. GDS, with its doubled-up stearic content, ramps up the feeling of richness and can help seal the barrier against dryness. At the end of a long, dry winter, a cream with GDS can comfort dry patches at night, while a summer face lotion with GMS keeps skin hydrated without feeling greasy.
Both ingredients pass safety checks around the world. The US Food and Drug Administration and the European Commission see these as safe for cosmetics and food uses. Both break down in the body into fatty acids and glycerin, which the body already deals with every day. But for anyone concerned about plant-based sourcing, it helps to look for products labeled vegan or palm-free, since manufacturers sometimes source stearic acid from palm oil or animal fats.
If you want to avoid clogged pores, a product with more GMS than GDS feels lighter and lets skin breathe. For those after deep comfort for rough or cracked skin, more GDS means a longer-lasting protective feel. The best choice depends on what your skin needs at the moment. Recognizing these small differences makes it easier to pick products that actually improve texture and boost comfort, instead of just filling space on the bathroom shelf.
Thinking about glyceryl monostearate (GMS) and glyceryl distearate, you often find them in foods and pharmaceuticals. These ingredients show up in baked goods, ice cream, and even some tablets. Food and drug manufacturers count on them for a creamy texture or to help ingredients blend smoothly. Sometimes it’s easy to forget that these scientific-sounding names refer to common substances. Glyceryl monostearate usually comes from plant oils or animal fats. Glyceryl distearate shares a similar background.
When labels mention BP, EP, or USP, they’re referencing major pharmacopoeias: British, European, and United States, respectively. Manufacturers who meet these requirements must prove their product passes strict purity tests. As a patient and consumer, seeing “pharma grade” means you get something that’s been through more checks for contaminants compared to food-grade additives. Makers test for heavy metals, residual solvents, and impurities. This rigorous screening gives confidence to healthcare workers who rely on safe excipients for tablets and creams.
Public health agencies and regulatory bodies, such as the FDA, have looked at these additives for decades. Glyceryl monostearate appears in the FDA’s list of food additives allowed for direct addition to food (21 CFR 184.1324). In research studies, even when consumed in amounts much higher than those found in a regular diet, GMS and its relatives have not been shown to harm laboratory animals or humans. European authorities, too, have not flagged any serious health concerns linked with recommended uses or doses. The Joint FAO/WHO Expert Committee on Food Additives has set an “acceptable daily intake” that far exceeds typical human exposure.
Although widely regarded as safe, there have been rare cases of allergic reactions. Symptoms might look like rash, redness, or digestive upset, though incidents remain uncommon. For people concerned about specific food allergies, knowing the additive source can matter—a batch could come from soy or palm oil, for instance. Also, excessive intake of any emulsifier in processed foods is not advisable for gut health. Some research connects high levels of certain emulsifiers to imbalances in gut bacteria, raising questions that deserve careful study. The key issue in these studies: They often use extreme doses not typical in everyday foods.
Better labeling helps people make informed choices. Pharma-grade GMS and glyceryl distearate give another layer of trust, thanks to verified levels of purity. Checking that your chosen supplement or medicine comes from a reputable manufacturer, reviewed by agencies like the FDA, is a strong defense. I always look for products with clear ingredient lists and a batch number in case a problem ever turns up during recalls or quality alerts. For people who rely on compounded drugs, asking the pharmacist about ingredient sources and grades is a good practice. Industry groups and regulators should keep pushing for transparency in sourcing and supply chain traceability.
Plenty of folks eat or take medicines with glyceryl monostearate and distearate every day with no issues. Medical and food researchers keep reviewing safety with updated methods, so any new concerns will get public attention. Manufacturers who use pharma-grade ingredients show extra care for patient safety. In daily life, the safest bet comes from choosing products with high standards and staying up to date with public advisories. That’s the backbone of consumer safety and trust.
Pharmaceutical applications don’t leave much room for error, so the details in ingredients like Glyceryl Monostearate (GMS) and Glyceryl Distearate matter a lot. Most people know these compounds as emulsifiers, but their story in medicines and supplements goes deeper. In the context of British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP), quality demands reach another level.
Purity standards shape how safe and effective any ingredient can be for patients. GMS and Distearate in pharmaceutical use usually carry a purity above 90%, sometimes edging closer to 98% or more. That level of quality comes from strict tests that screen out heavy metals, residual solvents, and impurities.
A supplier printing “Pharma Grade” on a drum doesn’t mean much without real numbers to back it up. For GMS, pharma specifications often cover:
Glyceryl Distearate follows a similar track:
In practice, most pharmaceutical companies look beyond labels and run their own in-house checks. Even after passing BP, EP, or USP, manufacturers retest to confirm the certificate matches real-world results.
Purity isn’t just a number tucked away in certificates. In my early days formulating semi-solids, I learned firsthand that off-spec GMS or Distearate can trigger everything from granulation failures to cloudiness in oral suspensions. One batch of “nearly pure” GMS led to stiff tablets that barely dissolved. The difference came down to just 2% impurity—enough to throw off drug release timing.
Makers of oral, topical, or injectable drugs want predictable behavior, whether you’re making a simple cream or a layered tablet. Higher purity translates to fewer unknowns, smoother regulatory approval, and less troubleshooting in the factory. Patients benefit too, since impurities might cause allergies or add side effects.
Getting the right grade doesn’t just happen at the supplier level. Routine monitoring—using HPLC or FTIR—can catch drift or mistakes before things reach patients. Pharma staff who stay vigilant with ingredients set a higher standard for safety.
Regulatory guidelines grow tighter every year, but chemistry challenges keep pace. Setting up supply agreements with real certificates, transparent traceability, and shared batch data helps take pressure off quality assurance. Buyers should not hesitate to demand samples, full Certificates of Analysis, and clarification on any deviation from published pharmacopoeial standards.
Commitment to quality means more than ticking boxes for audits. Regular training and strong links between formulation teams and their suppliers will catch subtle issues and drive improvements in ingredient choices. Glyceryl Monostearate and Distearate may play a supporting role in finished medicines, but the standards they meet help define patient safety every day.
Experience in pharmaceutical supply chains teaches that the real challenge with Glyceryl Monostearate (GMS) and Glyceryl Distearate often begins after delivery. These compounds, valued as emulsifiers and stabilizers, can easily spoil if left to the wrong corner of a warehouse. I remember one small lab cutting corners on storage, and the clumping they encountered due to excess humidity cost more in rework than they saved by skipping insulation. What this shows is that a cool, dry space forms the basis of good storage for such pharma-grade additives.
From direct practice, temperatures above 30°C compromise both compounds, particularly in non-climate-controlled regions. GMS and Distearate go soft, attract moisture, and lose the smooth powder or flake form needed for reliable processing. Pharmaceutical grades match tight quality parameters, and variations—even minor—cause batch-to-batch unpredictability down the line in tableting or creams.
Sealing these ingredients against exposure starts with the right packaging. Laminated or multi-layered polyethylene bags inside rigid drums or barrels provide a solid defense. Opened sacks left half-folded and unsealed invite airborne contaminants, and even ordinary cardboard can absorb vapor from warehouse spills. A team I worked with kept up appearances for auditors with shiny floors, but product recalls stemmed from trace humidity seeping through cheaper packaging. This highlights how product protection isn’t just an appearance issue.
Storing GMS or Distearate off the ground plays a role, too. Pallets keep drums away from condensation and any stray cleaning chemicals. In bulk storage, rotating inventory using “first in, first out” reduces the chance of aging stock, which can harden or create insoluble lumps over time. This isn’t busywork—each batch’s shelf life remains only as good as the oldest container’s last encounter with warm, stagnant air.
Direct exposure to GMS and Distearate doesn’t raise major health alarms like some solvents or acids, but dust in the eyes or nose causes discomfort. Simple measures often work best. Gloves, dust masks, and protective eyewear cut down most risks during weighing or transfer. I’ve seen careful scoop work by well-trained staff prevent more material loss, and cleaner air, than any filter system alone ever managed.
Tidy procedures matter. Spoons, scoops, and transfer tools must stay dry and free from residues left by previous ingredients. Cross-contamination becomes a bigger headache the more diverse a manufacturing site’s products get. Inconsistent cleaning today can show up weeks later as odd smells or off-colors in a supposedly “pure” formulation, setting off long investigations for quality teams.
Auditing isn’t just for regulators. Regular temperature and humidity checks, along with periodic inspection of sealed containers, go a long way toward catching problems before they snowball. Many flying visits to plants show that the best-performing teams spot rust on lids or soft bags long before mold or caked raw material enters production.
One answer for long-term dependability in pharma-grade GMS and Distearate storage rests on a culture of respect: respect for the product’s environment, for careful handling, and for vigilant record keeping. This habit doesn’t just shield a batch or two; it supports trust in every tablet or cream a patient receives down the line.
| Names | |
| Preferred IUPAC name | 2,3-Dihydroxypropyl octadecanoate and Propane-1,2,3-triyl bis(octadecanoate) |
| Other names |
GMS Glyceryl Stearate Monostearin Glycerin Monostearate Octadecanoic acid monoester with 1,2,3-propanetriol Stearic acid, monoester with glycerol |
| Pronunciation | /ɡlɪˈsɪrɪl ˌmɒnoʊˈstɪəreɪt ənd ˌdɪstɪəˈreɪt/ |
| Identifiers | |
| CAS Number | 31566-31-1 |
| Beilstein Reference | 1720998 |
| ChEBI | CHEBI:53783 |
| ChEMBL | CHEMBL1201493 |
| ChemSpider | 2733565 |
| DrugBank | DB11019 |
| ECHA InfoCard | 20-211-022-1 |
| EC Number | EC 289-782-3 |
| Gmelin Reference | 22,491 |
| KEGG | C02737 |
| MeSH | D000071224 |
| PubChem CID | 24699 |
| RTECS number | WK4025000 |
| UNII | Y4O2L3U82H |
| UN number | UN 3082 |
| Properties | |
| Chemical formula | C21H42O4 |
| Molar mass | 358.57 g/mol |
| Appearance | White or almost white, waxy flakes or powder |
| Odor | Odorless |
| Density | 0.97 g/cm³ |
| Solubility in water | Insoluble in water |
| log P | 3.2 |
| Basicity (pKb) | 8.1 |
| Refractive index (nD) | 1.448 – 1.455 |
| Viscosity | 4000 to 5000 CPS |
| Dipole moment | 1.3 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 709.2 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -16524 kJ/mol |
| Pharmacology | |
| ATC code | A16AX |
| Hazards | |
| Main hazards | May cause irritation to eyes, skin, and respiratory tract. |
| GHS labelling | GHS07, GHS08, Warning, H315, H319, H335 |
| Pictograms | GHS07, GHS08 |
| Signal word | Not Classified |
| Hazard statements | Hazard statements: Not classified as hazardous according to OSHA Hazard Communication Standard (29 CFR 1910.1200) or European Regulation (EC) No. 1272/2008 (CLP/GHS). |
| Precautionary statements | Keep container tightly closed. Store in a cool, dry place. Avoid contact with eyes, skin, and clothing. Wash thoroughly after handling. Use with adequate ventilation. Avoid breathing dust. |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | > 198°C |
| LD50 (median dose) | LD50 (oral, rat): > 20,000 mg/kg |
| PEL (Permissible) | 10 mg/m3 |
| REL (Recommended) | Recommended upto 3.0% |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Monoglycerides Glyceryl Stearate Glyceryl Distearate Glyceryl Palmitate Glyceryl Monooleate Stearic Acid Palmitic Acid |
Chengguan District, Lanzhou, Gansu, China
